We ask ourselves, what might be the hidden message behind this term. It’s easy! Treatment of rheumatoid arthritis (RA) is so complex that algorithms only work as setting a frame, in which personalized medicine is applied.
The idea, that genetics or serologic factors determine a preferable choice of drug, aren’t new. During the last ten yearsmuch work has been invested, however, we aren’t yet able to make choices on the basis of such parameters.